TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 3 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q1 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $180,000 | -72.6% | 200,000 | -71.4% | 0.00% | -66.7% |
| Q3 2018 | $657,000 | +0.9% | 700,000 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $651,000 | -82.3% | 700,000 | -80.0% | 0.01% | -94.3% |
| Q4 2013 | $3,680,000 | -35.7% | 3,500,000 | -36.4% | 0.10% | -40.3% |
| Q3 2013 | $5,722,000 | -1.3% | 5,500,000 | 0.0% | 0.18% | +0.6% |
| Q2 2013 | $5,797,000 | +1.3% | 5,500,000 | 0.0% | 0.18% | -19.4% |
| Q1 2013 | $5,720,000 | +2.4% | 5,500,000 | 0.0% | 0.22% | -26.9% |
| Q4 2012 | $5,588,000 | -5.1% | 5,500,000 | 0.0% | 0.30% | -32.3% |
| Q3 2012 | $5,887,000 | +2.5% | 5,500,000 | 0.0% | 0.44% | -12.0% |
| Q2 2012 | $5,742,000 | -4.0% | 5,500,000 | 0.0% | 0.50% | -19.0% |
| Q1 2012 | $5,984,000 | +4.9% | 5,500,000 | 0.0% | 0.62% | -29.8% |
| Q4 2011 | $5,705,000 | +1.7% | 5,500,000 | 0.0% | 0.88% | -13.3% |
| Q3 2011 | $5,612,000 | – | 5,500,000 | – | 1.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ZAZOVE ASSOCIATES LLC | 83,413,000 | $130,650,000 | 6.13% |
| AEGON USA Investment Management, LLC | 6,000,000 | $9,368,000 | 2.35% |
| MACKAY SHIELDS LLC | 24,370,000 | $38,152,000 | 2.07% |
| INCOME RESEARCH & MANAGEMENT | 4,374,000 | $6,829,000 | 1.11% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 20,000 | $20,347,000 | 0.99% |
| SHENKMAN CAPITAL MANAGEMENT INC | 5,269,000 | $8,264,000 | 0.82% |
| Mitsubishi UFJ Securities Holdings Co., Ltd. | 325,000 | $511,000 | 0.76% |
| PALISADE CAPITAL MANAGEMENT, LP | 9,299,000 | $14,598,000 | 0.47% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 14,543,000 | $23,021,000 | 0.35% |
| CSS LLC/IL | 3,750,000 | $5,893,000 | 0.35% |